Roslyn Davis

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9

Holly E. Careskey, Roslyn Davis, William E. Alborn et al. · Journal of Lipid Research · 2007 · 310 citations · Full text

Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine

A.R. Coulter, Rodney Harris, Roslyn Davis et al. · Vaccine · 2003 · 102 citations

Vaccination, Vaccinology, Vaccine Development +5

A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I

Rachael Easton, Andreas Gille, Denise D’Andrea et al. · The Journal of Clinical Pharmacology · 2013 · 84 citations

Thrombosis, Pharmaceutical Science, Csl112 Infusions +15

Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses

Sigrid Sjölander, Debbie Drane, Roslyn Davis et al. · Vaccine · 2001 · 61 citations

Mucosal Vaccination, Systemic Antibody, Cytotoxic T-lymphocyte Responses +11

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

B. Douglas Smith, Gail J. Roboz, Roland B. Walter et al. · Blood · 2014 · 60 citations